1. Home
  2. BCYC vs ULH Comparison

BCYC vs ULH Comparison

Compare BCYC & ULH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • ULH
  • Stock Information
  • Founded
  • BCYC 2009
  • ULH 1932
  • Country
  • BCYC United Kingdom
  • ULH United States
  • Employees
  • BCYC N/A
  • ULH N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • ULH Trucking Freight/Courier Services
  • Sector
  • BCYC Health Care
  • ULH Industrials
  • Exchange
  • BCYC Nasdaq
  • ULH Nasdaq
  • Market Cap
  • BCYC 529.8M
  • ULH 635.2M
  • IPO Year
  • BCYC 2019
  • ULH 2005
  • Fundamental
  • Price
  • BCYC $7.10
  • ULH $27.14
  • Analyst Decision
  • BCYC Buy
  • ULH Hold
  • Analyst Count
  • BCYC 12
  • ULH 1
  • Target Price
  • BCYC $22.91
  • ULH $29.00
  • AVG Volume (30 Days)
  • BCYC 261.8K
  • ULH 31.5K
  • Earning Date
  • BCYC 08-08-2025
  • ULH 07-24-2025
  • Dividend Yield
  • BCYC N/A
  • ULH 1.54%
  • EPS Growth
  • BCYC N/A
  • ULH N/A
  • EPS
  • BCYC N/A
  • ULH 2.31
  • Revenue
  • BCYC $19,281,000.00
  • ULH $1,668,148,000.00
  • Revenue This Year
  • BCYC $7.35
  • ULH N/A
  • Revenue Next Year
  • BCYC N/A
  • ULH $7.88
  • P/E Ratio
  • BCYC N/A
  • ULH $11.77
  • Revenue Growth
  • BCYC N/A
  • ULH N/A
  • 52 Week Low
  • BCYC $6.10
  • ULH $20.60
  • 52 Week High
  • BCYC $28.67
  • ULH $53.29
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 37.11
  • ULH 59.51
  • Support Level
  • BCYC $7.25
  • ULH $23.66
  • Resistance Level
  • BCYC $7.68
  • ULH $25.52
  • Average True Range (ATR)
  • BCYC 0.42
  • ULH 1.07
  • MACD
  • BCYC -0.07
  • ULH 0.24
  • Stochastic Oscillator
  • BCYC 12.80
  • ULH 98.67

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.

Share on Social Networks: